Attached files

file filename
8-K - 8-K - Colfax CORPcfx8-kx12312016earnings.htm

colfaxlogoa01a02a01a01a02a09.jpg


COLFAX REPORTS FOURTH QUARTER 2016 RESULTS

Exceeded full year 2016 guidance with fourth quarter net income per dilutive share of $0.31 and
adjusted net income per share of $0.46
Drove structural cost changes to improve profitability
Delivered 7% organic Gas and Fluid Handling order growth
Completed acquisition that expands welding automation solutions business

ANNAPOLIS JUNCTION, MD - February 2, 2017 - Colfax Corporation (NYSE: CFX), a leading global manufacturer of gas- and fluid-handling and fabrication technology products and services, today announced its financial results for the quarter and year ended December 31, 2016.

For the fourth quarter of 2016, net income was $37.8 million, or $0.31 per dilutive share, compared to $44.2 million, or $0.36 per dilutive share, for the fourth quarter of 2015. Adjusted net income was $56.9 million, or $0.46 per share, compared to $63.0 million, or $0.51 per share for the comparable 2015 period. Full year 2016 net income was $128.1 million, or $1.04 per dilutive share, and adjusted net income was $191.8 million, or $1.56 per share.

The Company reported fourth quarter net sales of $0.93 billion, compared with $1.06 billion in the comparable 2015 quarter. The decrease included a 2.8% decline from foreign currency exchange rates. Fourth quarter operating income was $66.0 million or 7.1% of sales, and adjusted operating income was $90.8 million or 9.7% of sales. The prior year fourth quarter operating income margin was 6.1%, and the adjusted operating income margin was 9.5%.

“We delivered another solid profit performance this quarter expanding our operating margins despite a revenue decrease,” said Matthew Trerotola, President and Chief Executive Officer. “Our teams effectively executed their global restructuring initiatives and significantly improved their cost positions. We also continued to apply CBS to improve commercial processes, contributing to the 7% organic increase in Gas and Fluid Handling orders in the quarter. This is the second consecutive quarter of order growth and was delivered in a stable, but not growing, end market environment. We believe this represents an early indication that our strategies to drive aftermarket and focus resources on the growing applications and regions are building momentum.”

“Market conditions have not fully recovered as we enter 2017, and we are well positioned to deliver the incremental $50 million of structural cost savings included in our 2017 forecast. At the same time, we are pivoting the organization more toward growth and increasing the pace of new product launches and investments in growth regions. This increasing focus on organic growth is complemented by a more active acquisition pipeline.”

In the fourth quarter, Colfax completed the acquisition of Arc Machines, Inc. (“AMI”) for cash consideration of approximately $26 million. AMI is a leader in automated orbital TIG welding for niche applications ranging from the thinnest wall high purity tube welds to the heaviest application of cladding or pipe welding. “Our strengthened ESAB team has made great progress on profitability and the pace of technology development, launching a wide range of new products to enable higher productivity for our customers.” Mr. Trerotola continued, “The acquisition of AMI builds on this progress, and we are very pleased to welcome the AMI team to ESAB and Colfax.”

Conference Call and Webcast

Colfax will host a conference call to provide details about its results on Thursday, February 2, 2017 at 8:00 a.m. EST. The call will be open to the public through 877-303-7908 (U.S. callers) or 678-373-0875 (international callers) and referencing the conference ID number 58639787, or through webcast via Colfax’s website at www.colfaxcorp.com under the “Investors” section. Access to a supplemental slide presentation can also be found at the Colfax website under the same heading. Both the audio of this call and the slide presentation will be archived on the website later today and will be available until the next quarterly call.



About Colfax Corporation

Colfax Corporation is a diversified global manufacturing and engineering company that provides gas- and fluid-handling and fabrication technology products and services to commercial and governmental customers around the world under the Howden, Colfax Fluid Handling and ESAB brands. Colfax believes that its brands are among the most highly recognized in each of the markets that it serves. Colfax is traded on the NYSE under the ticker “CFX.” Additional information about Colfax is available at www.colfaxcorp.com.

Non-GAAP Financial Measures and Other Adjustments

Colfax has provided in this press release financial information that has not been prepared in accordance with GAAP. These non-GAAP financial measures are adjusted net income, adjusted net income per share, adjusted operating income, adjusted operating income margin, organic sales decline and organic order growth (decline). Adjusted net income, adjusted net income per share, adjusted operating income and adjusted operating income margin exclude Restructuring and other related charges, Asbestos coverage adjustment, and charges associated with the deconsolidation of our operations in Venezuela to the extent they impact the periods presented. Adjusted net income and adjusted net income per share for the year ended December 31, 2015 exclude the write-off of certain deferred financing fees and original issue discount associated with the refinancing of Colfax’s credit agreement. The effective tax rates used to calculate adjusted net income and adjusted net income per share are 27.5% and 28.6% for the fourth quarter and full year ended December 31, 2016, respectively. The effective tax rates used to calculate adjusted net income and adjusted net income per share are 25.1% and 27.5% for the fourth quarter and full year ended December 31, 2015, respectively. Organic sales decline and organic order growth (decline) exclude the impact of acquisitions and foreign exchange rate fluctuations. These non-GAAP financial measures assist Colfax in comparing its operating performance on a consistent basis because, among other things, they remove the impact of restructuring and other related charges, asbestos coverage adjustments, Venezuela deconsolidation charges and write-off of certain deferred financing fees and original issue discount.

Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information calculated in accordance with GAAP. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures. A reconciliation of non-GAAP financial measures presented above to GAAP results has been provided in the financial tables included in this press release.

CAUTIONARY NOTE CONCERNING FORWARD LOOKING STATEMENTS:

This press release may contain forward-looking statements, including forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning Colfax’s plans, objectives, expectations and intentions and other statements that are not historical or current fact. Forward-looking statements are based on Colfax’s current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause Colfax’s results to differ materially from current expectations include, but are not limited to factors detailed in Colfax’s reports filed with the U.S. Securities and Exchange Commission including its 2015 Annual Report on Form 10-K under the caption “Risk Factors.” In addition, these statements are based on a number of assumptions that are subject to change. This press release speaks only as of the date hereof. Colfax disclaims any duty to update the information herein.

The term “Colfax” in reference to the activities described in this press release may mean one or more of Colfax’s global operating subsidiaries and/or their internal business divisions and does not necessarily indicate activities engaged in by Colfax Corporation.

Contact:

Terry Ross, Vice President of Investor Relations
Colfax Corporation
301-323-9054
Terry.Ross@colfaxcorp.com



Colfax Corporation
Consolidated Statements of Income
Dollars in thousands, except per share data
(Unaudited)


 
Three Months Ended
 
Year Ended
 
December 31, 2016
 
December 31, 2015
 
December 31, 2016
 
December 31, 2015
 
 
 
 
 
 
 
 
Net sales
$
933,751

 
$
1,061,464

 
$
3,647,047

 
$
3,967,053

Cost of sales
645,133

 
728,039

 
2,501,396

 
2,715,279

Gross profit
288,618

 
333,425

 
1,145,651

 
1,251,774

Selling, general and administrative expense
197,798

 
232,843

 
825,240

 
905,952

Asbestos coverage adjustment

 

 
8,226

 

Restructuring and other related charges
24,853

 
35,519

 
74,170

 
61,177

Operating income
65,967

 
65,063

 
238,015

 
284,645

Interest expense, net
5,393

 
10,593

 
30,016

 
47,743

Income before income taxes
60,574

 
54,470

 
207,999

 
236,902

Provision for income taxes
17,755

 
5,941

 
62,808

 
49,724

Net income
42,819

 
48,529

 
145,191

 
187,178

Less: income attributable to noncontrolling interest, net of taxes
5,047

 
4,332

 
17,080

 
19,439

Net income attributable to Colfax Corporation
$
37,772

 
$
44,197

 
$
128,111

 
$
167,739

Net income per share - basic
$
0.31

 
$
0.36

 
$
1.04

 
$
1.35

Net income per share - diluted
$
0.31

 
$
0.36

 
$
1.04

 
$
1.34






Colfax Corporation
Reconciliation of GAAP to Non-GAAP Financial Measures
Dollars in thousands, except per share data
(Unaudited)


 
Three Months Ended
 
Year Ended
 
December 31, 2016
 
December 31, 2015
 
December 31, 2016
 
December 31, 2015
Adjusted Operating Income
 
 
 
 
 
 
 
Operating income
$
65,967

 
$
65,063

 
$
238,015

 
$
284,645

Operating income margin
7.1
%
 
6.1
%
 
6.5
%
 
7.2
%
Asbestos coverage adjustment

 

 
8,226

 

Restructuring and other related charges
24,853

 
35,519

 
74,170

 
61,177

Loss on deconsolidation of Venezuelan operations

 

 
2,369

 

Adjusted operating income
$
90,820

 
$
100,582

 
$
322,780

 
$
345,822

Adjusted operating income margin
9.7
%
 
9.5
%
 
8.9
%
 
8.7
%

 
Three Months Ended
 
Year Ended
 
December 31, 2016
 
December 31, 2015
 
December 31, 2016
 
December 31, 2015
Adjusted Net Income and
Adjusted Net Income Per Share
 
 
 
 
 
 
 
Net income attributable to Colfax Corporation
$
37,772

 
$
44,197

 
$
128,111

 
$
167,739

Asbestos coverage adjustment

 

 
8,226

 

Restructuring and other related charges
24,853

 
35,519

 
74,170

 
61,177

Loss on deconsolidation of Venezuelan operations

 

 
2,369

 

Debt extinguishment charges- Refinancing of credit agreement

 

 

 
4,731

Tax adjustment(1)
(5,758
)
 
(16,678
)
 
(21,040
)
 
(33,549
)
Adjusted net income
$
56,867

 
$
63,038

 
$
191,836

 
$
200,098

Adjusted net income margin
6.1
%
 
5.9
%
 
5.3
%
 
5.0
%
Weighted-average shares outstanding - diluted
123,385

 
124,102

 
123,199

 
124,870

Adjusted net income per share
$
0.46

 
$
0.51

 
$
1.56

 
$
1.60

Net income per share— diluted
(in accordance with GAAP)
$
0.31

 
$
0.36

 
$
1.04

 
$
1.34

__________ 
(1) The effective tax rates used to calculate adjusted net income and adjusted net income per share are 27.5% and 28.6% for the fourth quarter and full year ended December 31, 2016, respectively, and 25.1% and 27.5% for the fourth quarter and full year ended December 31, 2015.



Colfax Corporation
Change in Sales, Orders and Backlog
Dollars in millions
(Unaudited)


 
Net Sales
 
Orders
 
 
 
$
 
%
 
$
 
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the three months ended December 31, 2015
$
1,061.5

 
 
 
$
425.0

 
 
 
 
 
 
Components of Change:
 
 
 
 
 
 
 
 
 
 
 
Existing Businesses
(98.2
)
 
(9.3
)%
 
29.6

 
7.0
 %
 
 
 
 
Acquisitions(1)
1.3

 
0.1
 %
 

 
 %
 
 
 
 
Foreign Currency Translation
(30.8
)
 
(2.8
)%
 
(11.6
)
 
(2.8
)%
 
 
 
 
Total
(127.7
)
 
(12.0
)%
 
18.0

 
4.2
 %
 
 
 
 
For the three months ended December 31, 2016
$
933.8

 
 
 
$
443.0

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net Sales
 
Orders
 
Backlog at Period End
 
$
 
%
 
$
 
%
 
$
 
%
 
 
 
 
 
 
 
 
 
 
 
 
As of and for the year ended December 31, 2015
$
3,967.1

 
 
 
$
1,794.8

 
 
 
$
1,140.9

 
 
Components of Change:
 
 
 
 
 
 
 
 
 
 
 
Existing Businesses
(223.8
)
 
(5.6
)%
 
(49.3
)
 
(2.7
)%
 
(66.6
)
 
(5.8
)%
Acquisitions(2)
52.9

 
1.3
 %
 
66.6

 
3.7
 %
 

 
 %
Foreign Currency Translation
(149.2
)
 
(3.8
)%
 
(59.8
)
 
(3.4
)%
 
(45.1
)
 
(4.0
)%
Total
(320.1
)
 
(8.1
)%
 
(42.5
)
 
(2.4
)%
 
(111.7
)
 
(9.8
)%
As of and for the year ended December 31, 2016
$
3,647.0

 
 
 
$
1,752.3

 
 
 
$
1,029.2

 
 
__________ 
(1) Represents the incremental sales as a result of our acquisition of AMI.
(2) Represents the incremental sales and orders as a result of our acquisitions of AMI, RootsTM blowers and compressors, and Simsmart Technologies.






Colfax Corporation
Consolidated Balance Sheets
Dollars in thousands, except share amounts
(Unaudited)


 
December 31,
 
2016
 
2015
ASSETS
 
 
 
CURRENT ASSETS:
 
 
 
Cash and cash equivalents
$
221,730

 
$
197,469

Trade receivables, less allowance for doubtful accounts of $41,511 and $39,505
913,614

 
888,166

Inventories, net
403,857

 
420,386

Other current assets
246,396

 
224,872

Total current assets
1,785,597

 
1,730,893

Property, plant and equipment, net
604,214

 
644,536

Goodwill
2,563,326

 
2,817,687

Intangible assets, net
899,340

 
995,712

Other assets
532,982

 
544,091

Total assets
$
6,385,459

 
$
6,732,919

 
 
 
 
LIABILITIES AND EQUITY
 
 
 
CURRENT LIABILITIES:
 
 
 
Current portion of long-term debt
$
5,406

 
$
5,792

Accounts payable
605,895

 
569,445

Customer advances and billings in excess of costs incurred
151,015

 
195,038

Accrued liabilities
344,358

 
346,069

Total current liabilities
1,106,674

 
1,116,344

Long-term debt, less current portion
1,286,738

 
1,411,755

Other liabilities
898,703

 
948,264

Total liabilities
3,292,115

 
3,476,363

Equity:
 
 
 
Common stock, $0.001 par value; 400,000,000 shares authorized; 122,780,261 and 123,486,425 issued and outstanding
123

 
123

Additional paid-in capital
3,199,682

 
3,199,267

Retained earnings
685,411

 
557,300

Accumulated other comprehensive loss
(988,345
)
 
(686,715
)
Total Colfax Corporation equity
2,896,871

 
3,069,975

Noncontrolling interest
196,473

 
186,581

Total equity
3,093,344

 
3,256,556

Total liabilities and equity
$
6,385,459

 
$
6,732,919





Colfax Corporation
Consolidated Statements of Cash Flows
Dollars in thousands
(Unaudited)
 
 
Year Ended December 31,
 
2016
 
2015
Cash flows from operating activities:
 
 
 
Net income
$
145,191

 
$
187,178

Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
Depreciation, amortization and impairment charges
143,258

 
154,542

Stock-based compensation expense
19,020

 
16,321

Non-cash interest expense
4,176

 
10,101

Deferred income tax benefit
(1,682
)
 
(22,717
)
Changes in operating assets and liabilities:
 
 
 
Trade receivables, net
(50,958
)
 
64,048

Inventories, net
19,665

 
(390
)
Accounts payable
52,308

 
2,548

Customer advances and billings in excess of costs incurred
(37,210
)
 
(21,094
)
Changes in other operating assets and liabilities
(46,794
)
 
(86,724
)
Net cash provided by operating activities
246,974

 
303,813

Cash flows from investing activities:
 
 
 
Purchases of fixed assets
(63,251
)
 
(69,877
)
Acquisitions, net of cash received
(25,992
)
 
(196,007
)
Other, net
7,249

 
18,927

Net cash used in investing activities
(81,994
)
 
(246,957
)
Cash flows from financing activities:
 
 
 
Borrowings under term credit facility

 
750,000

Payments under term credit facility
(37,500
)
 
(1,232,872
)
Proceeds from borrowings on revolving credit facilities and other
896,742

 
1,498,039

Repayments of borrowings on revolving credit facilities and other
(978,024
)
 
(1,104,055
)
Proceeds from issuance of common stock, net
2,206

 
6,052

Repurchases of common stock
(20,812
)
 
(27,367
)
Other
(7,830
)
 
(21,066
)
Net cash used in financing activities
(145,218
)
 
(131,269
)
Effect of foreign exchange rates on Cash and cash equivalents
4,499

 
(33,566
)
Increase (decrease) in Cash and cash equivalents
24,261

 
(107,979
)
Cash and cash equivalents, beginning of period
197,469

 
305,448

Cash and cash equivalents, end of period
$
221,730

 
$
197,469

 
 
 
 
Supplemental Disclosure of Cash Flow Information:
 
 
 
Interest payments
$
35,838

 
$
36,363

Income tax payments, net
77,104

 
79,540